Literature DB >> 17205531

Coffee and tea consumption and risk of hepatocellular carcinoma in Italy.

Maurizio Montella1, Jerry Polesel, Carlo La Vecchia, Luigino Dal Maso, Anna Crispo, Marina Crovatto, Pietro Casarin, Francesco Izzo, Luigi Gabriele Tommasi, Renato Talamini, Silvia Franceschi.   

Abstract

The role of coffee in the aetiology of hepatocellular carcinoma has raised great interest. In Italy, coffee consumption is high, thus allowing the investigation of the topic over a broad range of consumption. A hospital-based case-control study was conducted in Italy in 1999-2002, including 185 incidents, histologically confirmed cases of hepatocellular carcinoma aged 43-84 years. Controls were 412 subjects admitted to the same hospitals' networks for acute, non-neoplastic diseases unrelated to diet. Coffee and tea consumption were assessed using a validated food-frequency questionnaire. Odds ratios (ORs) and corresponding the 95% confidence intervals (CI) were computed using unconditional multiple logistic regression, adjusting for hepatitis viruses seropositivity, alcohol intake, smoking habits and other potential confounding factors. Compared to people who drunk <14 cups/week of coffee, the risk of hepatocellular carcinoma decreased for increasing levels of consumption (OR=0.4, 95% CI: 0.2-1.1 for >or=28 cups/week, p for trend = 0.02). In the present study, inverse relations were observed across strata of hepatitis C and, B virus infections and alcohol drinking. No significant association emerged with consumption of decaffeinated coffee (OR=0.7, 95% CI=0.2-2.5) or tea (OR=1.4, 95% CI=0.8-2.7). The present study supports the hypothesis of a favourable effect of coffee, though not decaffeinated coffee and tea, on the risk on hepatocellular carcinoma. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17205531     DOI: 10.1002/ijc.22509

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

Review 1.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

Review 2.  Tea and cancer prevention: epidemiological studies.

Authors:  Jian-Min Yuan; Canlan Sun; Lesley M Butler
Journal:  Pharmacol Res       Date:  2011-03-23       Impact factor: 7.658

3.  Green tea and liver cancer.

Authors:  Francesca Bravi; Carlo La Vecchia; Federica Turati
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

Review 4.  Non-viral causes of hepatocellular carcinoma.

Authors:  Wojciech Blonski; David S Kotlyar; Kimberly A Forde
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

Review 5.  Coffee Drinking and Reduced Risk of Liver Cancer: Update on Epidemiological Findings and Potential Mechanisms.

Authors:  Manami Inoue; Shoichiro Tsugane
Journal:  Curr Nutr Rep       Date:  2019-09

Review 6.  The changing pattern of epidemiology in hepatocellular carcinoma.

Authors:  Helena Nordenstedt; Donna L White; Hashem B El-Serag
Journal:  Dig Liver Dis       Date:  2010-07       Impact factor: 4.088

7.  Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population.

Authors:  Yanli Li; Shen-Chih Chang; Binh Y Goldstein; William L Scheider; Lin Cai; Nai-Chieh Y You; Heather P Tarleton; Baoguo Ding; Jinkou Zhao; Ming Wu; Qingwu Jiang; Shunzhang Yu; Jianyu Rao; Qing-Yi Lu; Zuo-Feng Zhang; Lina Mu
Journal:  Cancer Epidemiol       Date:  2011-02-10       Impact factor: 2.984

8.  Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study.

Authors:  Shane Johnson; Woon-Puay Koh; Renwei Wang; Sugantha Govindarajan; Mimi C Yu; Jian-Min Yuan
Journal:  Cancer Causes Control       Date:  2011-01-22       Impact factor: 2.506

9.  Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

Authors:  Neal D Freedman; James E Everhart; Karen L Lindsay; Marc G Ghany; Teresa M Curto; Mitchell L Shiffman; William M Lee; Anna S Lok; Adrian M Di Bisceglie; Herbert L Bonkovsky; John C Hoefs; Jules L Dienstag; Chihiro Morishima; Christian C Abnet; Rashmi Sinha
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

Review 10.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Katja Boehm; Francesca Borrelli; Edzard Ernst; Gabi Habacher; Shao Kang Hung; Stefania Milazzo; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.